Through advances in both basic and clinical scientific research, Pavlovian fear conditioning and extinction have become an exemplary translational model for understanding and treating anxiety disorders. Discoveries in associative and neurobiological mechanisms underlying extinction have informed techniques for optimizing exposure therapy that enhance the formation of inhibitory associations and their consolidation and retrieval over time and context. Strategies that enhance formation include maximizing prediction-error correction by violating expectancies, deepened extinction, occasional reinforced extinction, attentional control and removal of safety signals/behaviours. Strategies that enhance consolidation include pharmacological agonists of NMDA (i.e. D-cycloserine) and mental rehearsal. Strategies that enhance retrieval include multiple contexts, retrieval cues, and pharmacological blockade of contextual encoding. Stimulus variability and positive affect are posited to influence the formation and the retrieval of inhibitory associations. Inhibitory regulation through affect labelling is considered a complement to extinction. The translational value of extinction will be increased by more investigation of elements central to extinction itself, such as extinction generalization, and interactions with other learning processes, such as instrumental avoidance reward learning, and with other clinically relevant cognitive-emotional processes, such as self-efficacy, threat appraisal and emotion regulation, will add translational value. Moreover, framing fear extinction and related processes within a developmental context will increase their clinical relevance.
Introduction
Pavlovian fear conditioning and extinction has proved to be an illuminating translational model for understanding and treating fears and anxiety disorders. The basic science of classical conditioning and the clinical domain of fear and anxiety have a long history of close reciprocity since the seminal work of Watson & Rayner [1] who demonstrated how fear for originally neutral stimuli could be conditioned in a ninemonth infant (known as 'little Albert'). Using insights from Watson's work, Jones [2] developed a treatment for phobic fears that was the forerunner of modern exposure treatment. Further developed and refined by Wolpe [3] and many who followed, exposure is now viewed as the treatment of choice for anxiety disorders.
Exposure treatment involves repeated confrontation with feared stimuli (objects, situations, interoceptive cues or memories) in the absence of the feared outcome. Procedurally, this is equivalent to fear extinction, in which the conditional stimulus (CS) that was previously paired with an aversive outcome (unconditional stimulus, US) is repeatedly presented without being followed by the US. Stimulated by the high face validity of extinction as a model for exposure treatment, numerous studies in human and non-human animals have forged an ever-increasing connection between extinction and exposure, one that is unprecedented in the study of & 2018 The Author(s) Published by the Royal Society. All rights reserved. psychopathology and its treatment. A hallmark feature of extinction/exposure research has been the translation from animal laboratory studies, to laboratory studies of healthy humans and humans with strong fears albeit not necessarily disabling or leading to treatment-seeking (i.e. clinical analogue samples), and to laboratory and treatment studies with clinically severe samples.
From a learning perspective, the mechanisms of extinction learning have been relatively well established. Insights regarding the role of inhibitory processes in extinction marked a substantial advance with significant treatment implications [4] . Alongside these advances, fear extinction became a focal point for neuroscience [5] . The crucial brain structures and neural pathways have been documented in rodents, and research with healthy human subjects has confirmed the cross-species validity, suggesting that the behavioural and neural mechanisms underlying fear extinction have been strongly preserved across evolution [5] . Other studies have targeted alterations in the neural circuitry that mediate normal extinction in clinically anxious samples, which offer the potential for prediction of vulnerability to anxiety disorders and treatment response, and targets for treatment itself. In addition, research on neurotransmitter systems and signalling cascades has revealed potential targets for psychotherapeutic drug development. Drugs are now being evaluated as adjuncts to enhance the response to and generalization of exposure (e.g. D-cycloserine, scopolamine), and the potential for protein synthesis in the medial prefrontal cortex to be responsible for extinction in rodents offers pathways for newer pharmacological interventions [6] . Finally, the genetics of fear learning are the topic of much ongoing research, with growing evidence for genetic effects upon neural circuitries associated with conditioning and extinction in rodents and humans [7] . This combination of insights from psychological, neural, biochemical and genetic models provides an excellent foundation for translational science that is deserving of continued interaction among basic scientists and clinical scientists and more research funding [8] .
Learning psychology has offered more routes to fear reduction than extinction alone. Counterconditioning (such as provision of rewards for approach behaviours), USdeflation (such as reinterpretation of the US as less intense or harmful) and disruption of reconsolidation (i.e. interruption of the process through which fear memories are re-stabilized) provide alternative pathways to treatment, with the latter being a particular focus of recent research (as presented in other papers in this issue). Nonetheless, the translation from fear conditioning and extinction for exposure therapy is without doubt the most thoroughly substantiated by research. On the other hand, extinction/exposure research is not without challenges. Some of these are presented by clinical reality, one of the most important being that not all patients benefit sufficiently from exposure treatment, whereas others show return of fear or even full relapse. The inhibitory model of extinction provides a framework for the mechanisms by which fear returns (e.g. renewal, reinstatement, spontaneous recovery). Context-dependency of inhibitory associations renders extinction/exposure fragile relative to fear acquisition, and continued investigation of ways to decrease vulnerability to return of fear and relapse after exposure is necessary. Yet, return-of-fear phenomena themselves are quite vulnerable, insomuch as they are transient responses that subside with repeated extinction trials. From a clinical perspective, persistent exposure to formerly feared objects or situations weakens the return of fear; re-engagement in escape and avoidance following a return of fear, on the other hand, sustains fear responding. Recognition of the critical role of avoidance brings the Pavlovian study of fear extinction in contact with operant models (e.g. avoidance learning). We believe the area of classical-operant interactions offers promising advances and should become the focus of future research. Similarly, reward-related safety learning during extinction is emerging as an important topic that deserves further investigation. Another area is the clinical reality that exposure rarely targets all stimuli in a fear network. Further understanding of generalization of extinction/exposure across stimuli, and the interaction with generalization across contexts, is needed to enhance clinical application.
In addition to more investigation of processes central to extinction itself, such as generalization, and related processes such as operant avoidance and reward learning, we argue that the translational value of fear extinction can be further augmented by examining interactions between these learning processes and other clinically relevant cognitive-emotional processes such as self-efficacy, threat appraisal and emotion regulation. Finally, greater attention to developmental processes will enhance the translational value even further. With a more comprehensive model, combined with ongoing advances in the basic mechanisms underlying extinction, we will be better positioned to evaluate its predictive validity. For example, do individual differences in extinction predict the course and outcome of exposure treatment and do interventions that impact extinction affect exposure in similar ways?
Translation from fear extinction to exposure therapy
The history of exposure therapy is exemplary of the intertwining of basic science and clinical application. Exposure therapy refers to a set of therapeutic strategies for repeatedly and systematically approaching (rather than avoiding) feared objects (external or internal). Meta-analyses of many randomized controlled trials over the last several decades have demonstrated very large effect sizes for exposure therapy for anxiety disorders, whether alone or combined with coping strategies such as cognitive reappraisal or breathing/relaxation training [9] . Yet, while the majority improve within 10 to 20 weekly sessions of typical treatment trials, only approximately 55% achieve normative functioning [10] , and many experience a return of fear, defined as resurgence of fear from the end of exposure therapy to follow-up testing with the same object that was targeted during exposure therapy. Rates of return of fear vary by the methods for operationalization, but have been reported to occur in 19 to 62% [11] . Notably, not all whose fear returns fully relapse, possibly because of the continued approach to the stimulus despite fear (in which case fear will undergo re-extinction). Return of fear may explain the fluctuating course of panic symptoms following cognitive behavioural therapy which is only revealed by examining intra-individual patterns over time rather than the more typical evaluation of group means at specific time points following therapy completion [12] .
(a) Inhibitory retrieval model of extinction
Developments in basic science of extinction learning offered an explanation for return of fear. Specifically, the inhibitory rstb.royalsocietypublishing.org Phil. Trans. R. Soc. B 373: 20170025 retrieval model of extinction ascribes a central role to inhibitory learning, although additional mechanisms are likely to be involved [4] . The Pavlovian inhibitory learning model posits that the original CS-US association acquired during fear conditioning is not erased during extinction, but rather is left intact as new, secondary inhibitory learning about the CS-US develops-specifically, that the CS no longer predicts the US [13] . Consequently, the CS possesses two meanings following extinction: the original excitatory meaning (CS-US) and an inhibitory extinction meaning (CS-noUS). Research into the neural mechanisms supports this dual model, because the neurocircuitry underlying fear excitation (including basolateral and centromedial nuclei of the amygdala, dorsal anterior cingulate cortex and insular cortex) is distinct from the neurocircuitry underlying fear inhibition, particularly at the time of extinction retrieval (hippocampus and ventromedial prefrontal cortex). Arguably, when the test context is sufficiently similar to the extinction context, the hippocampus signals the vmPFC to activate local inhibitory networks in the amygdala that downregulate the centromedial nucleus and downstream fear reactions [5, 7] . Retention of, at least part of, the original excitatory association can be uncovered in several ways, including spontaneous recovery [14] , or increasing strength of the conditional response (CR) in proportion to the amount of time since the end of extinction. Clinically, this effect parallels return of fear with the lapse of time since the completion of exposure therapy. Second, because extinction learning is gated by context, renewal of conditional fear occurs if the surrounding context is changed between extinction and retest (e.g. ABA or ABC renewal) [4] . These effects have been observed experimentally in clinical analogue samples undergoing exposure therapy and follow-up testing in the same versus different contexts (see [15] for a review). Third, reinstatement of conditional fear occurs if unsignalled US presentations occur in between extinction and retest [16] ; by implication, adverse events following exposure therapy may lead to a return of fear of the previously feared stimulus if encountered in the context in which the unsignalled US occurred. Fourth, rapid reacquisition of the CR is seen if the CS-US pairings are repeated following extinction [17] , as may occur in dangerous environments. In addition to offering an explanation for return of fear following exposure therapy, these processes suggest possible pathways through which exposure therapy can be optimized to reduce the return of fear [15] .
(b) Dysregulation in inhibitory processes in anxious individuals
Individuals with anxiety disorders show dysregulation of inhibitory learning, with the most direct evidence from limitations in transfer of inhibition from a safe stimulus (i.e. B in a BX-compound) to an excitatory stimulus (i.e. A in AXþ compound) (i.e. AB , AX) [18] ; experimentally induced anxiety is also associated with transfer deficits relative to a novel stimulus (i.e. AB , AC) [19] (see [20] for contradictory findings).
Whether anxious individuals show deficits in safety transfer from social support figures, which have been explored as 'prepared safety stimuli' that inhibit conditional fear responses in healthy samples [21] , is yet to be investigated. Deficits in safety learning are inferred from differential conditioning paradigms, in which the stimulus paired with an innately aversive stimulus (CSþ) evokes conditional fear responding, whereas the stimulus that is never paired (CS2) is guided by inhibitory learning safety [22] . Conscious discrimination between CSþ and CS2 not only is impaired in individuals with anxiety disorders but also mediates spontaneous recovery of conditional fear in trait anxious individuals [23] . Furthermore, individuals with anxiety disorders exhibit elevated fear to the CS2 during fear acquisition relative to healthy controls [24] , which is suggestive of deficits in inhibitory safety learning. Elevated responding to the CS2 may also represent over-generalization of fear, which is more directly demonstrated through elevated fear to cues that perceptually resemble the CSþ [25] . In related fear potentiated startle paradigms, individuals prone to and who subsequently develop anxiety disorders show elevated responding to 'safe' visual stimuli (associated with no-shock instructions) in a context including 'danger' visual stimuli (associated with shock instructions), relative to neither individuals prone to nor those who develop anxiety disorders [26, 27] . Finally, anxious individuals show more elevated fear responding to the CSþ during extinction relative to healthy controls [24] . The effects are most clinically relevant when they persist, which has been shown for as much as one to two weeks later [28] .
Evidence is mounting that the vmPFC is critically involved in many if not all of the deficits in inhibitory processes listed above [5, 29, 30] . Notably, the findings extend from individuals with anxiety disorders to individuals exposed to early life stress, where impaired inhibitory extinction processes have been shown to involve the vmPFC and baslolateral amygdala [7] . The vmPFC is the human homologue of the infralimbic cortex in rodents, which is similarly implicated in impaired extinction processes as a function of stress [7] . Clearly, more research is needed to elucidate the neural correlates of fear inhibition across different anxiety disorders and across different inhibitory or safety learning paradigms.
Together, the evidence for impaired fear inhibition suggests that the very processes to be augmented during exposure therapy-to strengthen inhibitory associations and enhance their retrieval-may be impaired in individuals with anxiety disorders, which may, in part, explain the lower than desired response rate and higher than desired return of fear rate for exposure therapy. Indeed, deficiencies in inhibitory processes may represent a vulnerability for the onset of anxiety disorders. In the following section, we review the therapeutic strategies to augment exposure therapy derived from extinction learning. Some target the initial formation and consolidation of inhibitory representations (i.e. CS-noUS), others target their retrieval over time and context, and some target both. 
(c) Optimizing inhibitory associations during exposure
Extinction learning occurs when there is a mismatch between high US 'expectancy' and low actual rate or frequency with which USs occur (i.e. prediction error) [31] . Following this principle, strong disconfirmation of expectancies for threatening outcomes is hypothesized to facilitate the formation of inhibitory associations. The potency of repeated mismatches between US expectancy and US absence may explain why greater variation in US expectancy during extinction predicted lower US expectancy at follow-up test, above and beyond other indices [32] . Strategies designed to strengthen inhibitory associations during exposure therapy include behavioural rstb.royalsocietypublishing.org Phil. Trans. R. Soc. B 373: 20170025 conditions that explicitly violate expectancy (or create prediction error), attention to the CSþ, and removal of safety signals and safety behaviours. Variable CSs during exposure and variable timing of exposure trials as well as induced positive affect or positive affect specific to the CSþ may impact both the formation of inhibitory associations and their retrieval.
(i) Explicit violation of expectancy
Prediction error can be maximized by designing exposure tasks that specifically provide disconfirmatory experiences. For example, persons who fear dying from a prolonged panic attack would receive most violation of their expectancies from prolonged panic attacks that do not result in death. Supportive evidence for an 'expectancy violation' approach derives from a study with an acrophobic sample, in which as much long-term benefit occurred at follow-up with just one trial of 'expectancy disconfirming' exposure as with repeated trials of 'nondisconfirming' exposure each day. In another study, interoceptive exposure that continued until expectancy for an aversive outcome reached less than 5% was superior to standard (i.e. fear reduction-based) interoceptive exposure. Our trials with clinically severe samples routinely include this approach (see [15] ). More research is needed to fully validate this approach to exposure therapy across anxiety disorders.
The expectancy violation approach ties exposure parameters directly to consciously stated expectancies for aversive events and to that degree, overlaps with hypothesis testing experiments typical of cognitive treatment approaches for anxiety disorders. As we describe later, cognitive reappraisal can be incorporated within a learning theory perspective, thus providing a parsimonious theoretical framework, by mitigating conditional fear through reduction in the appraised intensity or valence of the US (i.e. US deflation) [33] . Yet, cognitive restructuring of threat overestimation prior to exposure may reduce US expectancy, and consequently net change in associative strength, thereby mitigating prediction-error extinction learning. For this reason, prediction-error models assert that cognitive restructuring is better reserved as a reinforcement strategy for the consolidation phase following exposure therapy.
The expectancy violation approach departs from models that emphasize fear reduction during exposure for long-term change. The amount by which fear reduces by the completion of extinction is not predictive of fear expressed at extinction retest in either animal or human laboratory samples [32, 34] . Similarly, the amount by which fear reduces by the end of exposure trials is not predictive of the fear level expressed at follow-up assessment in clinical analogue and clinically severe samples [35, 36] . In fact, maintaining arousal throughout exposure (versus habituation of arousal) may be beneficial because glucocorticoids enhance extinction consolidation [37] . These data point to the discord between the outward expression of fear on the one hand, and conditional associations indicative of underlying learning on the other hand.
(ii) Deepened extinction
In 'deepened extinction' [38] , multiple fear CSs are first extinguished separately before being combined, or a previously extinguished CS is paired with another to-be-extinguished CS. Deepened extinction has been shown to reduce spontaneous recovery and reinstatement of fear in animals [38] and humans [39] . Clinical translations include initial exposure to a single spider augmented by the addition of a second spider mid-session for spider fearful individuals, or exposure to close proximity to a loved one, followed by exposure to images of harming a loved one, followed by combining the two for individuals with obsessions of harming loved ones. Despite typical inclusion in exposure therapies, methods for deepened extinction are lacking full operationalization and further experimental investigation in analogue and clinical samples is needed.
(iii) Occasional reinforced extinction
Occasional reinforced extinction, or occasional CS-US pairings during extinction training, lessens rapid reacquisition of fear [40] . Aside from the enhanced ambiguity of the CS-US association that should be detrimental to rapid reacquisition, benefits may derive further opportunities for prediction error (on trials subsequent to CS-US trials when the US is absent) and [40] , occasional reinforced extinction sustained fear arousal during extinction, but attenuated the subsequent reacquisition of fear in a human conditioning study [41] . Although the high number of extinction trials and lean schedule of reinforced trials are intended to weaken return of fear while preventing resistance to extinction, the specific boundaries are not clear and may differ across species, responses and experimental designs [42] . Further investigation is needed with analogue and clinical samples, given the substantial implications of occasional negative outcomes (albeit limited to those within the range of normative human experience such as social rejection or panic attacks) within exposure therapy.
(iv) Attention to conditional stimulus
Key to prediction error is attention to both the CS and the nonoccurrence of the US because any change in associative strength (e.g. extinction learning) will be directed to the cue that is most salient [43] . Experimental manipulation of attention has proved difficult, although individuals who show more bias towards threat appear to achieve better outcomes from exposure therapy than individuals with less bias [44, 45] .
(v) Removal of safety signals and behaviours
Essential to prediction error is the removal of 'safety signals/ behaviours'. In the context of anxiety disorders, examples include the presence of another person, cell phones, medications, or reliance on stable structures to prevent falling. For persons who expect aversive outcomes contingent upon fear itself (i.e. individuals with social anxiety who fear humiliation should they exhibit fear), reduction of fear itself could become a safety signal. In laboratory studies, safety signals protect from extinction, an effect that is, in part, attributed to interference with the development of inhibitory associations [46] . Evidence from exposure therapy with phobic samples is mixed, with some indications of detrimental effects from the availability/ use of safety signals/behaviours during exposure therapy and others showing no effect [15] . Contradictions may derive from the failure to systematically control the ratio of number and strength of safety signals/behaviours relative to the number and strength of excitatory stimuli within clinical studies. Clearly, more systematic research is needed in analogue and clinical samples given the potential critical role of safety signals/behaviours and avoidance in general, and their predominance among anxious individuals.
(d) Optimizing consolidation of inhibitory associations immediately after exposure
To date, clinicians and patients have emphasized subjective reports (or lack thereof) of fear during exposure therapy as the critical index of learning, and yet extinction learning is likely to be highly dependent upon processes that occur in the intervals following exposure therapy and in ways that are not measurable through the conscious report of fear. A number of strategies have emerged to enhance consolidation of inhibitory associations.
(i) Mental rehearsal
Mental rehearsal of CS-US associations contributes to sustained conditional fear responding [47] , and mental rehearsal is important for memory consolidation more generally [48] . Hence, mental rehearsal of CS-noUS associations may enhance the retrieval of such inhibitory associations. For these reasons, following each exposure trial, we aim to consolidate learning by asking participants to judge what they learned regarding the non-occurrence of the feared event, discrepancies between what was predicted and what occurred, and the degree of 'surprise' from the exposure practice. Obviously, further research is needed on the topic of rehearsal and its timing (e.g. immediately following an extinction/exposure trial or over repeated days), especially as rehearsal immediately prior to a new exposure trial runs the risk of undermining prediction-error correction.
(ii) N-methyl-D-aspartate agonists Consolidation of extinction learning relies, in part, on N-methyl-D-aspartate (NMDA) receptors within the basolateral nucleus of the amygdala. The antibiotic D-cycloserine (DCS), a partial NMDA receptor agonist, was therefore posited to strengthen consolidation of inhibitory memories developed during extinction [49] , and a number of studies have since evaluated the value of adding DCS to exposure therapy. Meta-analyses have yielded mixed conclusions, from DCS improves exposure therapy when administered at low doses and close in time to exposures, to no evidence of clinical benefit [50, 51] . The contradictions have been attributed to mixing 'successful' (i.e. fear reduced) and 'unsuccessful' (i.e. fear did not reduce) exposure sessions, because DCS could augment fear learning if exposure was unsuccessful [52] . Yet, DCS enhances extinction memories more strongly than aversive memories in animal studies [53] . Moreover, as described above, fear reduction per se is not synonymous with CS-noUS inhibitory associations, such that DCS may enhance consolidation of CSnoUS associations even in the presence of sustained fear. More research is needed to identify specific populations for whom DCS augmentation of exposure therapy may be indicated, as well as other drugs that may enhance the acute and longterm effects of exposure. For example, pharmacological agents that regulate the stress response via inhibition of the renin-angiotensin system (i.e. losartan) may also enhance consolidation of extinction [54] .
(e) Optimizing retrieval of inhibitory associations after exposure therapy
Retrieval cues of the CS-noUS association that are present during fear extinction training as well as during novel contexts following completion of extinction reduce context renewal, at least when retrieval cues are positively valenced [55] . The risk of them acquiring inhibitory value and becoming a safety signal can be reduced by presenting the retrieval cue prior to the target CS, or on only a small percentage of trials, and ensuring that the cue is less salient than the target CS [56] . Clinically relevant examples might include an unusual object such as colourful pen, although investigation in a public speaking anxious sample yielded only minor benefits on context renewal [57] . Mental reinstatement can also act as a type of retrieval cue; spider fearful participants who were asked to recall 'where they were and what they learned' during prior exposure sessions showed less context renewal than those who recalled unrelated material [58] . (iii) Pharmacological blockade of contextual encoding
Areas of the hippocampus (particularly dentate gyrus and CA3) are critical to the encoding of temporal and spatial contextual information for learning events [7] . Procedures that interfere with encoding of contextual information offer the promise for reducing the context specificity of extinction learning and thereby reducing context renewal. Cholinergic neurotransmission is critical to learning, and scopolamine, a cholinergic receptor antagonist, has been shown to reduce contextual fear in rodent samples [59, 60] . Scopolamine, a relatively well-tolerated drug with few side effects, may reduce context renewal following exposure therapy. Studies are ongoing in this regard.
(f ) Additional strategies that optimize inhibitory associations and their retrieval (i) Stimulus variability
Varying the to-be-learned task enhances the retention of non-emotional material, possibly due to the enhancement of storage capacity of newly learned information, pairing information to-be-learned with more retrieval cues, and generation of a rule that captures the invariance among tasks [61] . Although this strategy did not originate from associative conditioning models, the effects can be explained by context retrieval models of extinction, because variability is more likely to characterize contexts in which phobic stimuli are encountered once exposure therapy is complete. Stimulus variability may also facilitate generalization from extinction/ exposure to related stimuli (generalization stimulus, GS), as described below. Furthermore, by introducing change, stimulus variability may enhance CS salience and prediction error, and thereby enhance not only retrieval of inhibitory associations but also their formation throughout exposure therapy. Variability in exposure timing and stimuli improved longterm exposure therapy outcomes in a series of clinical analogue samples (see [15] for review). Greater variability in fear levels throughout exposure (i.e. repeated increases following decreases in minute-to-minute fear levels) predicted superior longer-term outcomes (see [15] for review). Emotional variability may enhance generalization following exposure therapy, or may represent variations in expectancy for negative outcomes which provide additional opportunities for prediction error and development of inhibitory associations.
(ii) Positive affect
CSþ acquires fear arousal and negative valence during conditioning, with the latter relatively resistant to extinction and predictive of subsequent reinstatement of fear [62] .
Inductions that increase the positive valence of CSs during extinction/exposure reduced reinstatement in laboratory and analogue samples [63, 64] and lessened rapid reacquisition in a laboratory sample [65] . As positive affect enhances encoding, rehearsal, and retrieval of information, and relating incoming information to already-known information positive mood may augment the formation of inhibitory associations as well as their retrieval over time and context [66] . Methods for inducing positive affect at the moment that individuals with clinically severe anxiety approach feared situations are yet to be evaluated.
(g) Optimizing inhibitory regulation during exposure therapy
Labelling emotions represented in affective stimuli, such as an 'angry' face, or labelling emotional responses to stimuli, such as 'I feel afraid' (i.e. affect labelling) is regarded as a form of inhibitory regulation because of its activation of the right ventrolateral prefrontal cortex (RVLPFC) and inhibitory influences upon amygdala activity [67] . These processes are disrupted in clinically socially anxious individuals, where despite RVLPFC activation, amygdala activation is not blunted and is even increased in comorbid social anxiety and depression [68] . Although linguistic processing of affective stimuli did not emerge from Pavlovian associative learning, it may serve to complement or even augment the formation of inhibitory learning during extinction by increasing the attention to the CS and enhancing prediction error. In a series of analogue samples, affect labelling during exposure yielded longer-term benefits in terms of psychophysiological or behavioural responding [15, 69] .
We have yet to investigate whether affect labelling in these samples normalizes neural underpinnings. The clinical application encourages verbalization of emotional responses, as clients continue to approach their feared objects or situations and formal investigation is ongoing.
Future directions for fear extinction as a translational model
The inhibitory learning perspective has inspired novel ways to maximize the long-term outcome of exposure-based treatments. In addition to ongoing investigation of the neural and genetic correlates of extinction, further investigation is needed of fear extinction processes that are especially critical to understanding and treating fear and anxiety. For example, more investigation is needed on the topic of extinction generalization given that almost all treatments rely upon generalization CSs rather than original CSs. In addition, we argue that fear extinction will reach its full potential as a translational model when it is positioned centrally in relation to other relevant learning processes, and cognitive-emotional and developmental processes that are relevant to fear and anxiety. More detailed examination of their effects upon fear extinction is expected to inspire the next generation of exposure innovations (figure 2).
(a) Enhancing extinction generalization
Great progress has been made in terms of understanding the mechanisms by which humans and rodents acquire and extinguish fear within the context of a laboratory experiment. However, the reality outside the laboratory is more complex in a number of ways. One of the most significant challenges to exposure-based treatments is generalization of the beneficial rstb.royalsocietypublishing.org Phil. Trans. R. Soc. B 373: 20170025 effects of extinction. It is almost impossible to implement exposure to the entire range of objects and situations that trigger harm expectancy, let alone the original CS. Hence, treatment efficacy depends heavily upon generalizability beyond the specific objects and situations used during exposure. To date, the inhibitory learning perspective has focused largely upon generalization across contexts, because an extinction CS additionally needs the extinction context to successfully retrieve the CS-noUS extinction memory. Only recently has attention been given to the degree to which changes to the CS itself affect retrievability of the CS-noUS. The few extant human and rodent studies indicate that fear extinction with a changed CS (a GS) leads to return of fear to the original CS, much like the effects of context changes (i.e. similar to ABA renewal) [70, 71] . Interestingly, fear extinction with the original CS protects against return of fear when a GS is tested. Generalization-enhancing interventions may include extinguishing multiple variations of the CS (see Stimulus variability, section 2f(i)), manipulating attention during GS extinction towards common features rather than GS-specific features, and strategies that promote forgetting of specific features of the extinction CS (specific CS memory) [72] . The interaction between context and stimulus changes, which is of greatest clinical relevance, has yet to be investigated. Context changes may play dual opposing roles: they may promote forgetting of specific features of the extinction stimulus, thereby promoting generalization across variations of the stimulus, while they induce forgetting of the extinction association itself, thereby weakening extinction. Ideal is a strongly activated extinction association (to enhance retrieval of fear extinction) combined with a weakly activated stimulus memory (to enhance generalization of extinction). How to simultaneously enhance one component of the extinction memory (the noUS association) while weakening another (the stimulus representation) is one of the major challenges and yet one with great potential for the clinical field.
(b) Acting on fear: role of avoidance Fear is not an endpoint in itself, but a motivator for defensive actions. These include attempts to escape situations of acute threat and to pre-emptively avoid situations that convey impending threat. Unsurprisingly, individuals with anxiety disorders tend to avoid excessively, thereby limiting their experiences with the situations in which they perceive threat. Rigid avoidance is often disabling, leading to barriers in daily functioning and limiting the achievement of goals and rewards. Additionally, rigid avoidance precludes experiences with feared situations and hence opportunities to learn that the situations are actually safe (i.e. inhibitory associations/ fear extinction), thereby contributing to the persistence of anxiety disorders. For these reasons, exposure treatments are designed to approach situations that have been avoided. Albeit often underappreciated, return of fear is problematic only when accompanied by escape or avoidance behaviours. In the absence of escape or avoidance, return of fear would be followed by additional extinction and eventual fear reduction. As return of fear alone is a transient state, encouragement to tolerate fear throughout exposure sessions is particularly beneficial (see Stimulus variability and Optimizing inhibitory regulation during exposure therapy, sections 2f(i) and 2g). In fact, the success of an exposure treatment may be measured most accurately by the increase in approach than by the decrease in fear. In support, higher avoidance at pretreatment (and not higher fear) predicts poorer response to exposure-based treatments [73] .
It is of utmost importance to extend research on fear extinction to include avoidance behaviours. Avoidance learning can be modelled in the laboratory by adding instrumental control to the Pavlovian fear conditioning procedure. A rodent may avoid being shocked when it runs to another compartment of the cage upon presentations of a predictive CSþ. Likewise, a human volunteer may avoid an aversive shock to the fingers by pressing a button during a predictive CSþ. An early, surprising finding was that although avoidance is initially motivated by fear, it is probably not maintained by fear. Many studies have since confirmed that avoidance behaviours continue long after all signs of fear have declined [74] . Once the human/rodent has learned how to control the aversive stimulus, fear declines and avoidance behaviour comes under the control of other factors. Rodent studies have indicated an important role for the ventral striatum in avoidance learning, as well as connectivity with amygdala nuclei and prefrontal cortical areas, which has been confirmed in a handful of human brain imaging studies [75] . In sum, experimental studies have confirmed that the behavioural processes and neural circuitry of avoidance are, to some extent, different from fear. Changing avoidance may, therefore, require more than changing fear alone.
(c) Appetitive processes in extinction
Appetitive processes have been recently recognized in the omission of the US (i.e. prediction error), which has led to a focus upon reward-related safety prediction during extinction [76, 77] . Evidence to date, albeit nascent, implicates dopamine release in the ventral striatum. Given evidence for impaired safety learning in anxious individuals (see Dysregulation in inhibitory processes in anxious individuals, section 2b), the recent findings highlight the promise of pharmacological agents that enhance dopaminergic release during exposure therapy.
(d) Extension to other clinically relevant process
Cognitive-emotional processes such as self-efficacy, threat appraisal and emotion regulation are central to the evaluation of threat and hence the expression of fear and anxiety [78] . Yet, only a few studies have evaluated their influences upon fear conditioning and extinction. These include evidence for the neural effects of instructions to regulate emotions (by 'thinking of something calming') during CSþ trials to mimic neural effects of extinction [79, 80] . Furthermore, self-efficacy and cognitive reappraisal of feared stimuli as less threatening reduce fear conditioning and enhance fear extinction as measured via self-report or skin conductance [81] [82] [83] . Somewhat related is evidence for vicarious extinction of fear from observing others undergo fear extinction. Exposure involves a complex myriad that stretches far beyond simple fear inhibition learning as modelled in the standard fear extinction procedure. Processes related to early life adversity and ongoing life stress provide yet another piece to the puzzle, particularly in terms of individual differences that moderate fear conditioning and extinction that are being investigated in rodent samples and, to some extent, human samples [7] . The fact that some of these processes are difficult to model adequately in nonhuman animals points to the value of human pre-clinical and clinical research. Developmental maturational processes also influence fear conditioning and extinction, particularly with regard to greater deficits in safety learning in children relative to adolescents and adults, and greater deficits in extinction of fear expectancies in adolescents relative to adults, and deserve further attention [84] .
Conclusion
Fear extinction is a flagship of translational research that has informed the understanding and treatment of anxiety disorders. Ongoing investigation of extinction and its clinical application has led to new discoveries that have informed treatment development. These have included significant advances in understanding associative processes underlying extinction and neural correlates. Ongoing research continues to fuel more in-depth and comprehensive understanding of fear extinction, including extinction generalization, the role of appetitive processes in reward learning, operant processes of avoidance learning, cognitive-emotional processes involved in threat evaluation and developmental processes associated with normal maturation, early life adversity and life stress. As a function of continued scientific advancements and expansion to related processes suggested herein, fear extinction remains a viable and exemplary translational model for fear and anxiety disorders.
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